304 related articles for article (PubMed ID: 29241895)
1. Development and Validation of the AFImpact: An Atrial Fibrillation-Specific Measure of Patient-Reported Health-Related Quality of Life.
Coyne KS; Edvardsson N; Rydén A
Value Health; 2017 Dec; 20(10):1355-1361. PubMed ID: 29241895
[TBL] [Abstract][Full Text] [Related]
2. Atrial Fibrillation Impact Questionnaire (AFImpact): Validity and reliability of the Turkish version.
Zeren M; Demir R; Karcı M; Yiğit Z; Uzunhasan I; Gürses HN
Turk Kardiyol Dern Ars; 2021 Jul; 49(5):395-403. PubMed ID: 34308873
[TBL] [Abstract][Full Text] [Related]
3. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
[TBL] [Abstract][Full Text] [Related]
4. Validating the HeartQoL questionnaire in patients with atrial fibrillation.
Kristensen MS; Zwisler AD; Berg SK; Zangger G; Grønset CN; Risom SS; Pedersen SS; Oldridge N; Thygesen LC
Eur J Prev Cardiol; 2016 Sep; 23(14):1496-503. PubMed ID: 26976845
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Brod M; Blum SI; Bushnell DM; Ramasamy A
Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
[TBL] [Abstract][Full Text] [Related]
6. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).
Badia X; Arribas F; Ormaetxe JM; Peinado R; de Los Terreros MS
Health Qual Life Outcomes; 2007 Jul; 5():37. PubMed ID: 17610734
[TBL] [Abstract][Full Text] [Related]
7. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the AFSymp™: an atrial fibrillation-specific measure of patient-reported symptoms.
Medin J; Arbuckle R; Abetz L; Halling K; Kulich K; Edvardsson N; Coyne KS
Patient; 2014; 7(3):319-27. PubMed ID: 24733480
[TBL] [Abstract][Full Text] [Related]
9. New measure of health-related quality of life for patients with oropharyngeal mucositis: development and preliminary psychometric evaluation.
Cheng KK; Leung SF; Thompson DR; Tai JW; Liang RH; Kan AS; Ying FW; Yeung RM
Cancer; 2007 Jun; 109(12):2590-9. PubMed ID: 17492684
[TBL] [Abstract][Full Text] [Related]
10. Impact of Electrical Cardioversion on Quality of Life for the Treatment of Atrial Fibrillation.
Sandhu RK; Smigorowsky M; Lockwood E; Savu A; Kaul P; McAlister FA
Can J Cardiol; 2017 Apr; 33(4):450-455. PubMed ID: 28129962
[TBL] [Abstract][Full Text] [Related]
11. Development and psychometric testing of the self-care scale for patients with chronic atrial fibrillation (AF-SCS-10).
Son YJ; Baek KH; Won MH; Hong HC
Eur J Cardiovasc Nurs; 2020 Oct; 19(7):619-628. PubMed ID: 32340477
[TBL] [Abstract][Full Text] [Related]
12. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
Michaelis R; Meyer S; Reuber M; Schöne C
Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
[TBL] [Abstract][Full Text] [Related]
13. Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure.
Ahmad FS; Kallen MA; Schifferdecker KE; Carluzzo KL; Yount SE; Gelow JM; McCullough PA; Kimmel SE; Fisher ES; Cella D
Circ Heart Fail; 2019 Jun; 12(6):e005751. PubMed ID: 31163985
[TBL] [Abstract][Full Text] [Related]
14. Assessing the impact on caregivers of patients with schizophrenia: psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ).
Rofail D; Regnault A; le Scouiller S; Lambert J; Zarit SH
BMC Psychiatry; 2016 Jul; 16():245. PubMed ID: 27431493
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis.
Man A; Correa JK; Ziemek J; Simms RW; Felson DT; Lafyatis R
Ann Rheum Dis; 2017 Aug; 76(8):1374-1380. PubMed ID: 28213563
[TBL] [Abstract][Full Text] [Related]
16. Initial Psychometric Testing of the Knowledge About Atrial Fibrillation and Self-Management Survey.
McCabe PJ; Sendin MJ; Stuart-Mullen L; Kronebusch B; Fowler S; Krecke C; Kopecky S
J Cardiovasc Nurs; 2020; 35(1):35-44. PubMed ID: 31804248
[TBL] [Abstract][Full Text] [Related]
17. Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation.
Watanabe-Fujinuma E; Banderas BF; Koretsune Y; Kumagai K; Uchiyama S; Yamashita T; Yasaka M; Akiyama S; Briere JB; Dickie G; Cano SJ
J Med Econ; 2019 Aug; 22(8):798-805. PubMed ID: 30995146
[No Abstract] [Full Text] [Related]
18. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
19. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
[TBL] [Abstract][Full Text] [Related]
20. Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).
Brod M; Bushnell DM; Neergaard JS; Waldman LT; Busk AK
J Patient Rep Outcomes; 2023 Feb; 7(1):17. PubMed ID: 36821002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
